MEDICOX Co. Ltd Cash Flow Conversion Efficiency

Latest as of March 2025: -0.040x

MEDICOX Co. Ltd cash flow conversion efficiency. Based on the latest financial reports, MEDICOX Co. Ltd (054180) has a cash flow conversion efficiency ratio of -0.040x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.26 Billion ≈ $-1.53 Million USD) by net assets (₩56.22 Billion ≈ $38.10 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of MEDICOX Co. Ltd (2012–2024)

Cash flow conversion efficiency of MEDICOX Co. Ltd from 2012 to 2024. This chart illustrates how MEDICOX Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for MEDICOX Co. Ltd for real-time trading data and today's change.

MEDICOX Co. Ltd Cash Flow Conversion Ratio Explained

MEDICOX Co. Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

MEDICOX Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of MEDICOX Co. Ltd ranked by their cash flow conversion efficiency. Also see MEDICOX Co. Ltd (054180) market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Oxbridge Re Holdings Equity Warrant NASDAQ:OXBRW	0.067x
Schroder British Opportunities Trus LSE:SBO	-0.007x
Bharatiya Global Infomedia Limited NSE:BGLOBAL	-0.010x
PROMIS NEUROSCIENCES F:23J0	N/A
Ireka Corporation Bhd KLSE:8834	0.003x
Aptorum Group Ltd Class A NASDAQ:APM	-0.132x
Founder Group Limited Ordinary Shares NASDAQ:FGL	-0.841x
Ecoclime Group AB Series B ST:ECC-B	0.000x

Annual Cash Flow Conversion Efficiency for MEDICOX Co. Ltd (2012–2024)

The table below shows the annual cash flow conversion efficiency of MEDICOX Co. Ltd from 2012 to 2024. Review how much free cash does MEDICOX Co. Ltd generate to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩52.45 Billion ≈ $35.54 Million	₩-6.63 Billion ≈ $-4.50 Million	-0.126x	+11.47%
2023-12-31	₩62.24 Billion ≈ $42.18 Million	₩-8.89 Billion ≈ $-6.03 Million	-0.143x	+1.32%
2022-12-31	₩63.24 Billion ≈ $42.86 Million	₩-9.16 Billion ≈ $-6.20 Million	-0.145x	-32.31%
2021-12-31	₩66.20 Billion ≈ $44.87 Million	₩-7.24 Billion ≈ $-4.91 Million	-0.109x	+4.37%
2020-12-31	₩37.90 Billion ≈ $25.68 Million	₩-4.34 Billion ≈ $-2.94 Million	-0.114x	+23.98%
2019-12-31	₩21.17 Billion ≈ $14.34 Million	₩-3.19 Billion ≈ $-2.16 Million	-0.151x	-1297.78%
2018-12-31	₩21.22 Billion ≈ $14.38 Million	₩266.71 Million ≈ $180.74K	0.013x	+106.25%
2017-12-31	₩16.55 Billion ≈ $11.21 Million	₩-3.33 Billion ≈ $-2.25 Million	-0.201x	-835.66%
2016-12-31	₩19.11 Billion ≈ $12.95 Million	₩522.30 Million ≈ $353.96K	0.027x	-67.46%
2015-12-31	₩21.70 Billion ≈ $14.71 Million	₩1.82 Billion ≈ $1.23 Million	0.084x	+6.34%
2014-12-31	₩20.74 Billion ≈ $14.06 Million	₩1.64 Billion ≈ $1.11 Million	0.079x	+5.26%
2012-12-31	₩15.44 Billion ≈ $10.46 Million	₩1.16 Billion ≈ $785.10K	0.075x	--

About MEDICOX Co. Ltd

KQ:054180 Korea Aerospace & Defense

Market Cap

$573.12K

₩845.71 Million KRW

Market Cap Rank

#31002 Global

#2104 in Korea

Share Price

₩153.00

Change (1 day)

+0.00%

52-Week Range

₩153.00 - ₩153.00

All Time High

₩30388.84